Monkeypox: UKHSA laboratory assessments of inactivation methods
UKHSA has undertaken assessments of inactivation methods against monkeypox virus with further evaluations ongoing.
- From:
- UK Health Security Agency
- Published
- 22 August 2022
- Last updated
- 1 November 2022 — See all updates
Documents
Monkeypox virus inactivation testing report: NeuMoDx Vantage Viral Lysis Buffer
Ref: GOV-13490
PDF, 66.2 KB, 4 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Xpert CT/NG Swab Transport Reagent
Ref: GOV-13490
PDF, 42.9 KB, 4 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: DNA/RNA Shield Buffer (SafeCollect Swab Tube)
Ref: GOV-13490
PDF, 67.8 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Buffer ATL
Ref: GOV-13490
PDF, 96.1 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: NeuMoDx Viral Lysis Buffer
Ref: GOV-13490
PDF, 42.2 KB, 4 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Cobas PCR Media
Ref: GOV-12792
PDF, 223 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: PrimeStore Molecular Transport Medium
Ref: GOV-12792
PDF, 224 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Buffer AVL
Ref: GOV-12792
PDF, 218 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: 70% Ethanol
Ref: GOV-12792
PDF, 218 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: InhibiSURE Viral Inactivation Medium
Ref: GOV-12792
PDF, 221 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: L6 Buffer
Ref: GOV-12792
PDF, 217 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Nuclisens Lysis Buffer
Ref: GOV-12792
PDF, 218 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: MagBead Viral RNA Lysis Buffer
Ref: GOV-12792
PDF, 216 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Panther Fusion Specimen Lysis Tubes
Ref: GOV-12792
PDF, 225 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Monkeypox virus inactivation testing report: Molecular Sample Solution (MSS)
Ref: GOV-12792
PDF, 214 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Details
The UK Health Security Agency (UKHSA) has undertaken laboratory assessments of inactivation methods against the monkeypox virus to support the safe handling and processing of monkeypox samples.
The assessment of each inactivation method is summarised in an individual report.
Assessments are ongoing and will be published on this page as they are completed.
Updates to this page
Last updated 1 November 2022 + show all updates
-
Added 5 testing reports.
-
First published.